$ALXN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ALEXION PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ALEXION PHARMACEUTICALS, INC.. Get notifications about new insider transactions in ALEXION PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 10 ... 22 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Grant | A | 0.00 | 8,760 | 0 | 29,722 | 21 K to 29.7 K (+41.79 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Monnet Dominique | SVP, Chief Marketin ... | Grant | A | 0.00 | 2,538 | 0 | 5,538 | 3 K to 5.5 K (+84.60 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 11,690 | 0 | 36,116 | 24.4 K to 36.1 K (+47.86 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Grant | A | 0.00 | 8,760 | 0 | 36,060 | 27.3 K to 36.1 K (+32.09 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 173.75 | 1,665 | 289,294 | 23,160 | 24.8 K to 23.2 K (-6.71 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Grant | A | 0.00 | 8,760 | 0 | 24,825 | 16.1 K to 24.8 K (+54.53 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 173.93 | 2,920 | 507,876 | 126,013 | 128.9 K to 126 K (-2.26 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 11,690 | 0 | 128,933 | 117.2 K to 128.9 K (+9.97 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 173.98 | 8,660 | 1,506,667 | 950,048 | 958.7 K to 950 K (-0.90 %) |
Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 0.00 | 33,990 | 0 | 958,708 | 924.7 K to 958.7 K (+3.68 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 172.44 | 33 | 5,691 | 924,718 | 924.8 K to 924.7 K (0.00 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 174.38 | 2,190 | 381,892 | 924,751 | 926.9 K to 924.8 K (-0.24 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 174.25 | 3,000 | 522,750 | 926,941 | 929.9 K to 926.9 K (-0.32 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.38 | 608 | 106,023 | 117,243 | 117.9 K to 117.2 K (-0.52 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.02 | 765 | 133,125 | 117,851 | 118.6 K to 117.9 K (-0.64 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.37 | 676 | 117,874 | 155,706 | 156.4 K to 155.7 K (-0.43 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 174.06 | 895 | 155,784 | 156,382 | 157.3 K to 156.4 K (-0.57 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 172.79 | 4 | 691 | 16,065 | 16.1 K to 16.1 K (-0.02 %) |
Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | EVP, Chief HR Offic ... | Sell | S | 174.38 | 203 | 35,399 | 16,069 | 16.3 K to 16.1 K (-1.25 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 22.90 | 16,680 | 381,972 | 400,000 | |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 182.03 | 13,735 | 2,500,182 | 929,941 | 943.7 K to 929.9 K (-1.46 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 178.41 | 1,600 | 285,456 | 943,676 | 945.3 K to 943.7 K (-0.17 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 177.81 | 11,395 | 2,026,145 | 945,276 | 956.7 K to 945.3 K (-1.19 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 177.67 | 3,685 | 654,714 | 956,671 | 960.4 K to 956.7 K (-0.38 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 22.90 | 16,680 | 381,972 | 960,356 | 943.7 K to 960.4 K (+1.77 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 182.08 | 5,493 | 1,000,165 | 157,277 | 162.8 K to 157.3 K (-3.37 %) |
Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 182.03 | 5,494 | 1,000,073 | 113,122 | 118.6 K to 113.1 K (-4.63 %) |
Dec 16 2014 | ALXN | ALEXION PHARMACEUT ... | Brennan David R | Director | Buy | P | 186.99 | 500 | 93,495 | 1,268 | 768 to 1.3 K (+65.10 %) |
Dec 15 2014 | ALXN | ALEXION PHARMACEUT ... | Veneman Ann M | Director | Sell | S | 193.03 | 1,235 | 238,392 | 3,447 | 4.7 K to 3.4 K (-26.38 %) |
Dec 15 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | EVP & General Couns ... | Sell | S | 195.53 | 3,570 | 698,042 | 20,962 | 24.5 K to 21 K (-14.55 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 22.90 | 16,665 | 381,629 | 416,680 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 22.90 | 46,655 | 1,068,400 | 433,345 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 13,279 | 238,756 | 0 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 56,721 | 1,019,844 | 13,279 | |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 199.94 | 16,665 | 3,332,000 | 943,676 | 960.3 K to 943.7 K (-1.74 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 22.90 | 16,665 | 381,629 | 960,341 | 943.7 K to 960.3 K (+1.77 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 200.39 | 6,903 | 1,383,292 | 943,676 | 950.6 K to 943.7 K (-0.73 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 199.80 | 24,497 | 4,894,501 | 950,579 | 975.1 K to 950.6 K (-2.51 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 198.19 | 9,627 | 1,907,975 | 975,076 | 984.7 K to 975.1 K (-0.98 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 197.72 | 14,223 | 2,812,172 | 984,703 | 998.9 K to 984.7 K (-1.42 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 196.73 | 4,684 | 921,483 | 998,926 | 1 M to 998.9 K (-0.47 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 22.90 | 46,655 | 1,068,400 | 1,003,610 | 957 K to 1 M (+4.88 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 13,279 | 238,756 | 956,955 | 943.7 K to 957 K (+1.41 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 198.81 | 900 | 178,929 | 943,676 | 944.6 K to 943.7 K (-0.10 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 198.06 | 14,194 | 2,811,264 | 944,576 | 958.8 K to 944.6 K (-1.48 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 197.26 | 21,396 | 4,220,575 | 958,770 | 980.2 K to 958.8 K (-2.18 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 196.25 | 20,231 | 3,970,334 | 980,166 | 1 M to 980.2 K (-2.02 %) |
Dec 09 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 56,721 | 1,019,844 | 1,000,397 | 943.7 K to 1 M (+6.01 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | BURNS M MICHELE | Director | Buy | P | 167.32 | 10 | 1,673 | 788 | 778 to 788 (+1.29 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Option Exercise | M | 57.02 | 10,000 | 570,200 | 14,375 | |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Sell | S | 196.25 | 10,000 | 1,962,500 | 16,272 | 26.3 K to 16.3 K (-38.06 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Buy | M | 57.02 | 10,000 | 570,200 | 26,272 | 16.3 K to 26.3 K (+61.46 %) |
Dec 08 2014 | ALXN | ALEXION PHARMACEUT ... | KELLER WILLIAM R | Director | Sell | S | 196.25 | 5,000 | 981,250 | 7,276 | 12.3 K to 7.3 K (-40.73 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 20.90 | 20,000 | 418,000 | 100,000 | |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 30,000 | 539,400 | 1,832 | |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 25,000 | 449,500 | 31,832 | |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 202.76 | 200 | 40,552 | 162,770 | 163 K to 162.8 K (-0.12 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 201.79 | 11,358 | 2,291,931 | 162,970 | 174.3 K to 163 K (-6.52 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 200.82 | 5,782 | 1,161,141 | 174,328 | 180.1 K to 174.3 K (-3.21 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 199.53 | 3,447 | 687,780 | 180,110 | 183.6 K to 180.1 K (-1.88 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 198.28 | 3,468 | 687,635 | 183,557 | 187 K to 183.6 K (-1.85 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 197.45 | 3,438 | 678,833 | 187,025 | 190.5 K to 187 K (-1.81 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 196.46 | 9,037 | 1,775,409 | 190,463 | 199.5 K to 190.5 K (-4.53 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.55 | 13,270 | 2,594,949 | 199,500 | 212.8 K to 199.5 K (-6.24 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 20.90 | 20,000 | 418,000 | 212,770 | 192.8 K to 212.8 K (+10.38 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 30,000 | 539,400 | 192,770 | 162.8 K to 192.8 K (+18.43 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 200.16 | 25,000 | 5,004,000 | 162,770 | 187.8 K to 162.8 K (-13.31 %) |
Dec 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 25,000 | 449,500 | 187,770 | 162.8 K to 187.8 K (+15.36 %) |
Nov 24 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 191.96 | 5,210 | 1,000,112 | 943,676 | 948.9 K to 943.7 K (-0.55 %) |
Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Option Exercise | M | 18.01 | 15,000 | 270,150 | 15,000 | |
Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Sell | S | 195.66 | 15,000 | 2,934,900 | 4,840 | 19.8 K to 4.8 K (-75.60 %) |
Nov 13 2014 | ALXN | ALEXION PHARMACEUT ... | PARVEN ALVIN S | Director | Buy | M | 18.01 | 15,000 | 270,150 | 19,840 | 4.8 K to 19.8 K (+309.92 %) |
Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 5,693 | 102,360 | 56,832 | |
Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.00 | 5,693 | 1,110,135 | 162,770 | 168.5 K to 162.8 K (-3.38 %) |
Nov 10 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.98 | 5,693 | 102,360 | 168,463 | 162.8 K to 168.5 K (+3.50 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | M | 104.86 | 9,375 | 983,063 | 65,625 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 191.52 | 9,375 | 1,795,500 | 24,426 | 33.8 K to 24.4 K (-27.74 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | M | 104.86 | 9,375 | 983,063 | 33,801 | 24.4 K to 33.8 K (+38.38 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 17.65 | 14,336 | 253,030 | 0 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 22.90 | 15,664 | 358,706 | 84,336 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.02 | 14,336 | 2,724,127 | 118,616 | 133 K to 118.6 K (-10.78 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.00 | 15,664 | 2,976,160 | 132,952 | 148.6 K to 133 K (-10.54 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 17.65 | 14,336 | 253,030 | 148,616 | 134.3 K to 148.6 K (+10.68 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 22.90 | 15,664 | 358,706 | 134,280 | 118.6 K to 134.3 K (+13.21 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 30,000 | 539,400 | 62,525 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.98 | 17,475 | 314,201 | 92,525 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Option Exercise | M | 17.65 | 1,832 | 32,335 | 0 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 193.36 | 1,089 | 210,569 | 162,770 | 163.9 K to 162.8 K (-0.66 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 192.60 | 1,400 | 269,640 | 163,859 | 165.3 K to 163.9 K (-0.85 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 191.40 | 8,231 | 1,575,413 | 165,259 | 173.5 K to 165.3 K (-4.74 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 190.56 | 19,280 | 3,673,997 | 173,490 | 192.8 K to 173.5 K (-10.00 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.96 | 30,000 | 538,800 | 192,770 | 162.8 K to 192.8 K (+18.43 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Sell | S | 195.18 | 19,307 | 3,768,340 | 162,770 | 182.1 K to 162.8 K (-10.60 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.96 | 17,475 | 313,851 | 182,077 | 164.6 K to 182.1 K (+10.62 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Sinha Vikas | EVP & CFO | Buy | M | 17.65 | 1,832 | 32,335 | 164,602 | 162.8 K to 164.6 K (+1.13 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Option Exercise | M | 89.23 | 28,125 | 2,509,594 | 46,875 | |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Sell | S | 190.52 | 935 | 178,136 | 27,300 | 28.2 K to 27.3 K (-3.31 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Sell | S | 190.50 | 27,190 | 5,179,695 | 28,235 | 55.4 K to 28.2 K (-49.06 %) |
Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Islam Saqib | SVP, Chief Strat & ... | Buy | M | 89.23 | 28,125 | 2,509,594 | 55,425 | 27.3 K to 55.4 K (+103.02 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | M | 92.65 | 10,000 | 926,500 | 12,812 | |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 190.00 | 73 | 13,870 | 24,532 | 24.6 K to 24.5 K (-0.30 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 189.49 | 9,927 | 1,881,067 | 24,605 | 34.5 K to 24.6 K (-28.75 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Buy | M | 92.65 | 10,000 | 926,500 | 34,532 | 24.5 K to 34.5 K (+40.76 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Option Exercise | M | 78.88 | 3,075 | 242,556 | 7,737 | |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Option Exercise | M | 42.66 | 2,475 | 105,584 | 0 | |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 189.00 | 2,069 | 391,041 | 106,508 | 108.6 K to 106.5 K (-1.91 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 188.36 | 3,841 | 723,491 | 108,577 | 112.4 K to 108.6 K (-3.42 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Buy | M | 78.88 | 3,075 | 242,556 | 112,418 | 109.3 K to 112.4 K (+2.81 %) |
Oct 28 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Buy | M | 42.66 | 2,475 | 105,584 | 109,343 | 106.9 K to 109.3 K (+2.32 %) |
Oct 08 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Option Exercise | M | 92.65 | 10,000 | 926,500 | 22,812 | |
Oct 08 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Sell | S | 179.00 | 10,000 | 1,790,000 | 24,532 | 34.5 K to 24.5 K (-28.96 %) |
Oct 08 2014 | ALXN | ALEXION PHARMACEUT ... | Moriarty John B | SVP & General Couns ... | Buy | M | 95.65 | 10,000 | 956,500 | 34,532 | 24.5 K to 34.5 K (+40.76 %) |
Oct 07 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Option Exercise | M | 42.66 | 10,025 | 427,667 | 2,475 | |
Oct 07 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 174.95 | 4,925 | 861,629 | 106,868 | 111.8 K to 106.9 K (-4.41 %) |
Oct 07 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 169.95 | 5,100 | 866,745 | 111,793 | 116.9 K to 111.8 K (-4.36 %) |
Oct 07 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Buy | M | 42.66 | 10,025 | 427,667 | 116,893 | 106.9 K to 116.9 K (+9.38 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | SQUINTO STEPHEN P | EVP, Chief Global O ... | Sell | S | 159.50 | 76 | 12,122 | 106,868 | 106.9 K to 106.9 K (-0.07 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 166.72 | 4,338 | 723,231 | 948,886 | 953.2 K to 948.9 K (-0.46 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.43 | 14,837 | 2,454,485 | 953,224 | 968.1 K to 953.2 K (-1.53 %) |
Sep 26 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 164.83 | 40,825 | 6,729,185 | 968,061 | 1 M to 968.1 K (-4.05 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.65 | 32,047 | 565,630 | 0 | |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 161.45 | 12,388 | 2,000,043 | 1,008,886 | 1 M to 1 M (-1.21 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 160.53 | 19,169 | 3,077,200 | 1,021,274 | 1 M to 1 M (-1.84 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 159.87 | 12,878 | 2,058,806 | 1,040,443 | 1.1 M to 1 M (-1.22 %) |
Sep 18 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.65 | 32,047 | 565,630 | 1,053,321 | 1 M to 1.1 M (+3.14 %) |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Option Exercise | A | 164.16 | 25,000 | 4,104,000 | 25,000 | |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | Miller Edward | SVP, Chief Complian ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 12,199 | 219,338 | 130,000 | |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.38 | 12,199 | 2,017,471 | 1,021,274 | 1 M to 1 M (-1.18 %) |
Sep 12 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Grant | A | 17.98 | 12,199 | 219,338 | 1,033,473 | 1 M to 1 M (+1.19 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 21,214 | 381,428 | 142,199 | |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 90,919 | 1,634,724 | 163,413 | |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Option Exercise | M | 17.98 | 85,668 | 1,540,311 | 254,332 | |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.11 | 21,214 | 3,502,644 | 1,021,274 | 1 M to 1 M (-2.03 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 21,214 | 381,428 | 1,042,488 | 1 M to 1 M (+2.08 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.39 | 3,718 | 614,920 | 1,021,274 | 1 M to 1 M (-0.36 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 164.86 | 25,165 | 4,148,702 | 1,024,992 | 1.1 M to 1 M (-2.40 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 163.81 | 23,939 | 3,921,448 | 1,050,157 | 1.1 M to 1.1 M (-2.23 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 162.82 | 25,274 | 4,115,113 | 1,074,096 | 1.1 M to 1.1 M (-2.30 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 161.91 | 12,823 | 2,076,172 | 1,099,370 | 1.1 M to 1.1 M (-1.15 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 90,919 | 1,634,724 | 1,112,193 | 1 M to 1.1 M (+8.90 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 170.35 | 9,299 | 1,584,085 | 1,021,274 | 1 M to 1 M (-0.90 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 169.54 | 12,700 | 2,153,158 | 1,030,573 | 1 M to 1 M (-1.22 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 168.17 | 4,029 | 677,557 | 1,043,273 | 1 M to 1 M (-0.38 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 167.23 | 14,740 | 2,464,970 | 1,047,302 | 1.1 M to 1 M (-1.39 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 166.31 | 20,392 | 3,391,394 | 1,062,042 | 1.1 M to 1.1 M (-1.88 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 165.26 | 24,508 | 4,050,192 | 1,082,434 | 1.1 M to 1.1 M (-2.21 %) |
Sep 08 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Buy | M | 17.98 | 85,668 | 1,540,311 | 1,106,942 | 1 M to 1.1 M (+8.39 %) |
Sep 04 2014 | ALXN | ALEXION PHARMACEUT ... | Carmichael Clare | SVP, Chief HR Offic ... | Sell | S | 169.46 | 304 | 51,516 | 16,272 | 16.6 K to 16.3 K (-1.83 %) |
Aug 29 2014 | ALXN | ALEXION PHARMACEUT ... | BELL LEONARD | CEO | Sell | S | 169.17 | 5,912 | 1,000,133 | 1,021,274 | 1 M to 1 M (-0.58 %) |